writing and Parkinson’s advocacy. Mathur’s quick diagnosis is not the norm. Most younger patients are misdiagnosed, leading to delays in treatment and disease management. They also face ...
Fox Foundation, found that an overwhelming 84% of patients with Parkinson's disease report struggling with sleep issues. These were strongly linked to increased symptoms of depression, greater ...
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Sold as Onapgo, this device gives a steady dose of apomorphine – a medicine that helps people with Parkinson’s disease move more easily – under the skin to help manage movement issues and ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback